Natural Compounds from Mexican Medicinal Plants as Potential Drug Leads for Anti-Tuberculosis Drugs

作者：Gomez Cansino Rocio; Laura Guzman Gutierrez Silvia; Guadalupe Campos Lara Maria; Ines Espitia Pinzon Clara; Reyes Chilpa Ricardo^*

来源：ANAIS DA ACADEMIA BRASILEIRA DE CIENCIAS, 2017, 89(1): 31-43.

DOI：10.1590/0001-3765201720160298

• Tuberculosis
• medicinal plants
• natural products
• Mycobacterium tuberculosis

In Mexican Traditional Medicine 187 plant species are used in the treatment of respiratory conditions that may be associated with tuberculosis. In this contribution, we review the ethnobotany, chemistry and pharmacology of 63 species whose extracts have been assayed for antimycobacterial activity in vitro. Among these, the most potent is Aristolochia brevipes (MIC= 12.5 mu g/mL), followed by Aristolochia taliscana, Citrus sinensis, Chrysactinia mexicana, Persea americana, and Olea europaea (MIC<64 mu g/mL). Other potent extracts (inhibition > 95%, 50 mu g/mL) include: Amphipterygium adstringens, Larrea divaricata, and Phoradendron robinsoni. Several active compounds have been identified, the most potent are: Licarin A (isolated from A. taliscana), and 9-amino-9-methoxy-3,4-dihydro-2H-benzo[h]-chromen-2-one (transformation product of 9-methoxytariacuripyrone isolated from Aristolochia brevipes), both with MIC= 3.125 mu g/mL, that is 8-fold less potent than the reference drug Rifampicin (MIC= 0.5 mu g/mL). Any of the compounds or extracts here reviewed has been studied in clinical trials or with animal models; however, these should be accomplished since several are active against strains resistant to common drugs.

• 出版日期2017-3